Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Haematological Cancer”

146 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 146 results

Early research (Phase 1)Study completedNCT02678338
What this trial is testing

CAMELLIA: Anti-CD47 Antibody Therapy in Haematological Malignancies

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Gilead Sciences 20
Not applicableStudy completedNCT03067350
What this trial is testing

Influence of a Combined Pharmacogenetic Score on Through Plasma Voriconazole Concentrations in Haematological Patients

Who this might be right for
Invasive AspergillosisHaematological Cancer PatientsVoriconazole
University Hospital, Grenoble 47
Not applicableStudy completedNCT03664427
What this trial is testing

Pharmacogenetics of VOD in Children With HSCT

Who this might be right for
Cancer
Assistance Publique - Hôpitaux de Paris 436
Large-scale testing (Phase 3)UnknownNCT06238336
What this trial is testing

Clinical Study of CAR-T Technology for the Treatment of Relapsed Refractory Malignant Haematological Tumours

Who this might be right for
Hematological Malignancy
Shanxi Bethune Hospital 30
Not applicableUnknownNCT03750994
What this trial is testing

Economic Evaluation of Innovative Molecular Analyses in Onco-haematology

Who this might be right for
Haematological Malignancy
Assistance Publique - Hôpitaux de Paris 3,960
Not applicableLooking for participantsNCT06546631
What this trial is testing

Investigating Mechanistic Predictors of Interpatient Variability and Temozolomide (TMZ) Induced Haematological Toxicity for Glioma Patients

Who this might be right for
Glioma
University College Cork 55
Testing effectiveness (Phase 2)Study completedNCT04630756
What this trial is testing

AZD4573 in Novel Combinations With Anti-cancer Agents in Patients With Advanced Blood Cancer

Who this might be right for
Advanced Haematological Malignancies
AstraZeneca 40
Not applicableStudy completedNCT05450367
What this trial is testing

Predictive Markers of Response and Toxicity in Patients With a Haematological Malignancy Treated With Immunotherapy.

Who this might be right for
Blood Cancer
Assistance Publique - Hôpitaux de Paris 249
Large-scale testing (Phase 3)Looking for participantsNCT06988475
What this trial is testing

DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations

Who this might be right for
Solid TumourHaematological MalignancyMalignant Neoplasm+8 more
Cancer Research UK 30
Large-scale testing (Phase 3)Looking for participantsNCT05770037
What this trial is testing

DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers

Who this might be right for
Haematological MalignancyMalignant NeoplasmLymphoproliferative Disorders+8 more
Cancer Research UK 30
Testing effectiveness (Phase 2)Study completedNCT00460694
What this trial is testing

Allogeneic Cytokine-induced Killer Immunotherapy for Relapse After Allogeneic Marrow Transplant for Haematological Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myeloid Leukemia+4 more
Singapore General Hospital 24
Not applicableLooking for participantsNCT06150469
What this trial is testing

Efficacy of Inhaled Aromatherapy on Nausea and Vomiting in Hematological Malignancies

Who this might be right for
Hematological Malignancies
University Hospital, Limoges 286
Testing effectiveness (Phase 2)Ended earlyNCT02065869
What this trial is testing

Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell Transplant

Who this might be right for
Acute Lymphoblastic LeukemiaLeukemia, Acute Myeloid (AML), ChildLymphoma, Non-Hodgkin+10 more
Bellicum Pharmaceuticals 187
Not applicableStudy completedNCT00348959
What this trial is testing

An Evaluation of the Effect of 'Open Window' on Psychological Well-being and Experience of Stem Cell Transplantation

Who this might be right for
Hematological Malignancies
St. James's Hospital, Ireland 198
Large-scale testing (Phase 3)Looking for participantsNCT05722886
What this trial is testing

DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial) - Master Screening Protocol

Who this might be right for
Haematological MalignancySolid Tumour
Cancer Research UK 825
Not applicableUnknownNCT05174546
What this trial is testing

New Diagnostics in Neutropenia

Who this might be right for
Febrile Neutropenia
The University of Queensland 100
Not applicableUnknownNCT03659162
What this trial is testing

Efflux Pump Mediated Azole Resistance in Candida Albicans

Who this might be right for
Fungal Infection
Assiut University 100
Large-scale testing (Phase 3)UnknownNCT00934557
What this trial is testing

Randomized Study of ATG for Graft Versus Host Disease (GVHD) Prevention in Paediatric Patients Given an Unrelated Donor Stem Cell Transplantation

Who this might be right for
Paediatric Patients Affected by Haematological Malignancies and Eligible to Undergo HSCT From an Unrelated Volunteer
Fondazione IRCCS Policlinico San Matteo di Pavia 42
Not applicableLooking for participantsNCT05376566
What this trial is testing

Hydrochloric Acid Lock Therapy for Central Line-associated Bloodstream Infections

Who this might be right for
Central Line-associated Bloodstream Infection (CLABSI)
Rigshospitalet, Denmark 250
Not applicableLooking for participantsNCT06797037
What this trial is testing

Proof of Concept to Assess the Feasibility of a Decentralised Pathway Coordinated by the Advanced Practice Nurse for Patients Receiving Oral Treatment for Cancer or Malignant Haemopathy (ACCELER PLATFORM)

Who this might be right for
Solid CancerHaematological Malignancies
Institut Claudius Regaud 33
Load More Results